Skip to main content
Premium Trial:

Request an Annual Quote

Axxam Licenses Genedata's Screener Software

NEW YORK (GenomeWeb News) – Axxam has licensed Genedata’s data analysis and management software for use in its high-throughput screening programs, Genedata said today.
 
The multi-year agreement allows Axxam to implement the Genedata Screener software.
 
Axxam CEO Stefan Lohmer said the company’s focus extends beyond the actual license agreement to “a comprehensive, long-term partnership in high throughput screening.”
 
Genedata said the Screener’s architecture integrates with Axxam’s existing infrastructures and that it can be tailored for specific discovery processes.
 
Financial terms of the agreement were not released.
 

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more